Amneal Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q2 2017 to Q3 2018

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Amneal Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from Q2 2017 to Q3 2018.
  • Amneal Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2018 was $17.4M, a 62.5% increase year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Depreciation for 2023 was $66.2M, a 2.79% decline from 2022.
  • Amneal Pharmaceuticals, Inc. annual Depreciation for 2022 was $68.1M, a 12.2% increase from 2021.
  • Amneal Pharmaceuticals, Inc. annual Depreciation for 2021 was $60.7M, a 0.46% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2018 $17.4M +$6.68M +62.5% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $15.5M +$5.8M +60.1% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q3 2017 $10.7M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $9.65M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.